Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. JOHMPE [इंटर्नेट]. 27 फ़रवरी, 2025 [उल्लेखित 24 अगस्त, 2026];3(1). पर उपलब्ध: https://shmpublisher.com/index.php/johmpe/article/view/547